225
Views
11
CrossRef citations to date
0
Altmetric
Articles

Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy

, , , , &
Pages 382-387 | Received 03 Sep 2016, Accepted 14 Jan 2017, Published online: 17 May 2017

References

  • Hung YJ, Lee CH, Chu NF, et al. Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care 2010;33(8):1840–4.
  • Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414(6865):782–7.
  • Pan XR, Yang WY, Li GW, et al. Prevalence of diabetes and its risk factors in China, 1994. National diabetes prevention and control cooperative group. Diabetes Care 1997;20(11):1664–9.
  • Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003;46(9):1190–8.
  • Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. New England J Med 2010;362(12):1090–101.
  • Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013;310(9):948–59.
  • Hu D, Fu P, Xie J, et al. Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: The InterASIA study. Diabetes Res Clin Pract 2008;81(2):250–7.
  • Nathan DM. Long-term complications of diabetes mellitus. New England J Med 1993;328(23):1676–85.
  • Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic nephropathy in the United States and the United Kingdom. J Diabetes Compl 2004;18(1):18–26.
  • Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 2013;24(2):302–8.
  • de Boer IH, Rue TC, Hall YN, et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011;305(24):2532–9.
  • Varghese SA, Powell TB, Budisavljevic MN, et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 2007;18(3):913–22.
  • Tabaei BP, Al-Kassab AS, Ilag LL, et al. Does microalbuminuria predict diabetic nephropathy? Diabetes Care 2001;24(9):1560–6.
  • Dihazi H, Muller GA, Lindner S, et al. Characterization of diabetic nephropathy by urinary proteomic analysis: Identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem 2007;53(9):1636–45.
  • Perlemoine C, Beauvieux MC, Rigalleau V, et al. Interest of cystatin C in screening diabetic patients for early impairment of renal function. Metabolism 2003;52(10):1258–64.
  • Hojs R, Bevc S, Antolinc B, et al. Serum cystatin C as an endogenous marker of renal function in the elderly. Int J Clin Pharmacol Res 2003;24(2–3):49–54.
  • Hafizi S, Dahlback B. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily FEBS J 2006;273(23):5231–44.
  • Goruppi S, Ruaro E, Schneider C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 1996;12(3):471–80.
  • McCloskey P, Fridell YW, Attar E, et al. GAS6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. J Biol Chem 1997;272(37):23285–91.
  • Fridell Y-WC, Villa J, Attar EC, et al. GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J Biol Chem 1998;273(12):7123–6.
  • Nagai K, Arai H, Yanagita M, et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 2003;278(20):18229–34.
  • Nagai K, Matsubara T, Mima A, et al. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int 2005;68(2):552–61.
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15(7):539–53.
  • Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem 2009;46(3):205–17.
  • Hung Y-J, Lee C-H, Shieh Y-S, et al. Gender differences in plasma growth arrest-specific protein 6 levels in adult subjects. Clin Chim Acta 2015;441:1–5.
  • Clauser S, Peyrard S, Gaussem P, et al. Development of a novel immunoassay for the assessment of plasma Gas6 concentrations and their variation with hormonal status. Clin Chem 2007;53(10):1808–13.
  • Jerums G, Premaratne E, Panagiotopoulos S, et al. New and old markers of progression of diabetic nephropathy. Diabetes Res Clin Pract 2008;82:S30–S7.
  • Erek-Toprak A, Bingol-Ozakpinar O, Karaca Z, et al. Association of plasma growth arrest-specific protein 6 (Gas6) concentrations with albuminuria in patients with type 2 diabetes. Renal Fail 2014;36(5):737–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.